Search | WHO COVID-19 Research Database

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Show: 20 | 50 | 100

Results 1 - 14 de 14

Filter

Gefapixant in the treatment of chronic coughing.

Kuhlein, T.; Hasford, C.; Nitschmann, S..

Zeitschrift fur Allgemeinmedizin ; 99(2):62-64, 2023.

Article in German | EMBASE | ID: covidwho-20238207

[Myocarditis and pericarditis after COVID-19 mRNA vaccination]. / Myokarditis und Perikarditis nach COVID-19-mRNA-Impfung.

Augustin, Max; Hallek, M; Nitschmann, S.

Inn Med (Heidelb) ; 63(12): 1323-1326, 2022 Dec.

Article in German | MEDLINE | ID: covidwho-2103846

Subject(s)

COVID-19 Vaccines , COVID-19 , Myocarditis , Pericarditis , Humans , Myocarditis/etiology , Pericarditis/etiology , RNA, Messenger , Vaccination/adverse effects , COVID-19 Vaccines/adverse effects

Myokarditisrisiko bei mRNA-Impfstoffen zur Prävention von COVID-19 Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19

Augustin, M.; Hallek, M.; Nitschmann, S..

Der Internist ; : 1-3, 2022.

Article in German | EuropePMC | ID: covidwho-1733026

[Risk of myocarditis associated with mRNA vaccines for prevention of COVID-19]. / Myokarditisrisiko bei mRNA-Impfstoffen zur Prävention von COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 63(4): 461-464, 2022 04.

Article in German | MEDLINE | ID: covidwho-1733960

Subject(s)

COVID-19 , Myocarditis , COVID-19/prevention & control , Humans , Myocarditis/diagnosis , Myocarditis/prevention & control , Vaccines, Synthetic/adverse effects , mRNA Vaccines

[Development of vaccines for prevention of COVID-19 in adolescents]. / Impfstoffentwicklung zur Prävention von COVID-19 bei Jugendlichen.

Augustin, M; Hallek, M; Nitschmann, S; Nitschmann, S; Augustin, M; Hallek, M.

Internist (Berl) ; 62(12): 1360-1363, 2021 Dec.

Article in German | MEDLINE | ID: covidwho-1499411

Subject(s)

COVID-19 , Vaccines , Adolescent , Humans , SARS-CoV-2

[Anticoagulation in patients with COVID-19]. / Antikoagulation bei Patienten mit COVID-19.

Pekrul, I; Spannagl, M; Nitschmann, S.

Internist (Berl) ; 62(11): 1253-1255, 2021 Nov.

Article in German | MEDLINE | ID: covidwho-1460292

Subject(s)

COVID-19 , Anticoagulants/adverse effects , Blood Coagulation , Humans , SARS-CoV-2

[Inhaled budesonide in the treatment of COVID-19]. / Inhalatives Budesonid zur Therapie bei COVID-19.

Kluge, S; Nitschmann, S; Scherer, M.

Internist (Berl) ; 62(8): 887-889, 2021 Aug.

Article in German | MEDLINE | ID: covidwho-1287423

Subject(s)

Budesonide , COVID-19 , Administration, Inhalation , Bronchodilator Agents/therapeutic use , Humans , SARS-CoV-2

[Development of vaccines for prevention of COVID-19: part 3]. / Impfstoffentwicklung zur Prävention von COVID-19 Teil 3.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 62(6): 690-693, 2021 Jun.

Article in German | MEDLINE | ID: covidwho-1245600

Subject(s)

COVID-19 , Vaccines , Humans , SARS-CoV-2 , Vaccination

[Antibody therapy in patients with COVID-19]. / Antikörpertherapie bei Patienten mit COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 62(5): 572-576, 2021 May.

Article in German | MEDLINE | ID: covidwho-1179027

Subject(s)

COVID-19 , Antibodies, Viral , Humans , Immunoglobulin G , SARS-CoV-2

10.

[Development of vaccines for prevention of COVID-19]. / Impfstoffentwicklung zur Prävention von COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 62(1): 106-110, 2021 Jan.

Article in German | MEDLINE | ID: covidwho-1080607

Subject(s)

COVID-19 Vaccines , COVID-19/prevention & control , Humans

11.

[Development of vaccines for prevention of COVID-19: part 2]. / Impfstoffentwicklung zur Prävention von COVID-19 Teil 2.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 62(3): 337-340, 2021 Mar.

Article in German | MEDLINE | ID: covidwho-1070813

Subject(s)

COVID-19 Vaccines/therapeutic use , COVID-19/prevention & control , Humans

12.

[Morphological and molecular changes in the lung of COVID-19 patients]. / Morphologische und molekulare Veränderungen der Lungen von Patienten mit COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 61(12): 1304-1307, 2020 Dec.

Article in German | MEDLINE | ID: covidwho-935230

Subject(s)

COVID-19 , Lung/physiopathology , Pneumonia, Viral , Humans , Pandemics , Patients , SARS-CoV-2

13.

[Remdesivir for patients with COVID-19]. / Remdesivir bei Patienten mit COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 61(8): 869-872, 2020 Aug.

Article in German | MEDLINE | ID: covidwho-627543

Subject(s)

Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Coronavirus Infections/drug therapy , Pneumonia, Viral/drug therapy , Adenosine Monophosphate/therapeutic use , Alanine/therapeutic use , Betacoronavirus , COVID-19 , Humans , Pandemics , SARS-CoV-2 , COVID-19 Drug Treatment

14.

[Remdesivir for patients with severe COVID-19]. / Remdesivir bei Patienten mit schwerer COVID-19.

Augustin, M; Hallek, M; Nitschmann, S.

Internist (Berl) ; 61(6): 644-645, 2020 Jun.

Article in German | MEDLINE | ID: covidwho-116919

Subject(s)

Adenosine Monophosphate/analogs & derivatives , Alanine/analogs & derivatives , Antiviral Agents/therapeutic use , Coronavirus Infections/drug therapy , Pneumonia, Viral/drug therapy , Adenosine Monophosphate/therapeutic use , Alanine/therapeutic use , COVID-19 , Humans , Pandemics , Severity of Illness Index

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL